Beyond Air, Inc. Interest Expense Nonoperating
Beyond Air, Inc. (XAIR) reported Interest Expense Nonoperating of $1.49 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-08-13
- Beyond Air, Inc. interest expense nonoperating for the quarter ending 2026-06-30 was $1.49M, a 172.26% increase year-over-year.
- Beyond Air, Inc. interest expense nonoperating for the quarter ending 2026-03-31 was $1.24M, a 113.79% increase year-over-year.
- Beyond Air, Inc. interest expense nonoperating for the quarter ending 2025-12-31 was $1.09M, a 98.18% increase year-over-year.
- Beyond Air, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $639.00K, a 31.07% decline year-over-year.
- Beyond Air, Inc. interest expense nonoperating for fiscal 2026 was $3.52M, a 16.43% increase from fiscal 2025.
- Beyond Air, Inc. interest expense nonoperating for fiscal 2025 was $3.02M, a 3.67% increase from fiscal 2024.
- Beyond Air, Inc. interest expense nonoperating for fiscal 2024 was $2.91M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.49M 10-Q · filed 2026-08-13 | $2.73M derived: sum of 2 quarters · filed 2026-08-13 | $3.82M derived: sum of 3 quarters · filed 2026-08-13 | $4.46M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | $2.33M derived: sum of 2 quarters · filed 2026-06-26 | $2.97M derived: sum of 3 quarters · filed 2026-06-26 | $3.52M 10-K · filed 2026-06-26 |
| 2025-12-31 | $1.09M 10-Q · filed 2026-02-13 | $1.73M derived: sum of 2 quarters · filed 2026-02-13 | $2.27M 10-Q · filed 2026-02-13 | $2.85M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | $639.00K 10-Q · filed 2025-11-10 | $1.19M 10-Q · filed 2025-11-10 | $1.77M derived: sum of 3 quarters · filed 2026-08-13 | $2.32M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $548.00K 10-Q · filed 2026-08-13 | $1.13M derived: sum of 2 quarters · filed 2026-08-13 | $1.68M derived: sum of 3 quarters · filed 2026-08-13 | $2.60M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $580.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | $1.13M derived: sum of 2 quarters · filed 2026-06-26 | $2.06M derived: sum of 3 quarters · filed 2026-06-26 | $3.02M 10-K · filed 2026-06-26 |
| 2024-12-31 | $549.00K 10-Q · filed 2026-02-13 | $1.48M derived: sum of 2 quarters · filed 2026-02-13 | $2.44M 10-Q · filed 2026-02-13 | $3.36M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-09-30 | $927.00K 10-Q · filed 2025-11-10 | $1.89M 10-Q · filed 2025-11-10 | $2.81M derived: sum of 3 quarters · filed 2025-11-10 | $3.73M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $964.00K 10-Q · filed 2025-08-12 | $1.89M derived: sum of 2 quarters · filed 2025-08-12 | $2.80M derived: sum of 3 quarters · filed 2025-08-12 | $3.72M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $921.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-20 | $1.84M derived: sum of 2 quarters · filed 2025-06-20 | $2.75M derived: sum of 3 quarters · filed 2025-06-20 | $2.91M 10-K · filed 2025-06-20 |
| 2023-12-31 | $919.00K 10-Q · filed 2025-02-10 | $1.83M derived: sum of 2 quarters · filed 2025-02-10 | $1.99M 10-Q · filed 2025-02-10 | |
| 2023-09-30 | $914.00K 10-Q · filed 2024-11-12 | $1.07M 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $158.00K 10-Q · filed 2024-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |